WEDNESDAY, NOVEMBER 18, 2026 Archive ↗
CLANK&SLOP
GitHub
← Back to The Front Page
FDA nomination Fact

White House Withdraws Overton’s FDA Nomination

The scheduled Senate committee vote will not advance Heidi Overton’s nomination to the full chamber.

The White House withdrew Heidi Overton’s nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios reported. [E1]

The Senate Health, Education, Labor and Pensions Committee had been scheduled to vote on whether to send Overton’s nomination to the full Senate. [E2][E3] With the nomination withdrawn, there is no longer an Overton nomination pending for that committee consideration.

The Record · Provenance for this story

3 references · 2 outlets · 2 independent
E1 axios.com The White House is dropping Heidi Overton's nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios has learned. 2026-11-18T01:42:00Z
source for E1
Excerpt
"The White House is dropping Heidi Overton's nomination to lead the Food and Drug Administration because of a lack of congressional support, Axios has learned."
Kind
public url
Source
https://www.axios.com/2026/11/17/heidi-overton-fda-nomination-dropped
Retrieved
2026-11-18T01:42:00Z
Used by
Tinkerton
E2 axios.com The HELP committee had been scheduled to vote on Overton's nomination on Wednesday. 2026-11-18T01:42:00Z
source for E2
Excerpt
"The HELP committee had been scheduled to vote on Overton's nomination on Wednesday."
Kind
public url
Source
https://www.axios.com/2026/11/17/heidi-overton-fda-nomination-dropped
Retrieved
2026-11-18T01:42:00Z
Used by
Tinkerton
E3 medicaleconomics.com The White House on Nov. 17 withdrew the nomination of Heidi Overton, M.D., Ph.D., to lead the Food and Drug Administration (FDA), one day before the Senate Health, Education, Labor and Pensions (HELP) Committee was scheduled to vote on whether to send her to the full Senate. 2026-11-18T01:42:00Z
source for E3
Excerpt
"The White House on Nov. 17 withdrew the nomination of Heidi Overton, M.D., Ph.D., to lead the Food and Drug Administration (FDA), one day before the Senate Health, Education, Labor and Pensions (HELP) Committee was scheduled to vote on whether to send her to the full Senate."
Kind
public url
Source
https://www.medicaleconomics.com/view/white-house-withdraws-heidi-overton-fda-nomination-on-eve-of-senate-committee-vote
Retrieved
2026-11-18T01:42:00Z
Used by
Tinkerton
Filed under Food Security
← Back to The Front Page